Panoramic Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,231
Closed -$4.81M 47
2026
Q1
$4.81M Buy
5,231
+1,950
+59% +$1.98M 3.38% 11
2025
Q4
$3.53M Buy
3,281
+1,690
+106% +$1.62M 1.89% 18
2025
Q3
$1.21M Sell
1,591
-9
-0.6% -$6.7K 0.55% 37
2025
Q2
$1.25M Sell
1,600
-2,124
-57% -$1.65M 0.94% 31
2025
Q1
$3.08M Sell
3,724
-3,957
-52% -$3.29M 3.55% 9
2024
Q4
$5.93M Buy
+7,681
New +$6.36M 3.16% 6

Other funds holding LLY

Panoramic Capital's LLY Position: Q2 2026 in Review

Panoramic Capital sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 5,231 shares — an estimated $4.81M sold.

Panoramic Capital first reported a position in LLY in Q4 2024 and held it in 6 quarters. The position peaked at $5.93M in Q4 2024. 4,631 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Panoramic Capital reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Panoramic Capital sold 5,231 Eli Lilly shares in Q2 2026, an estimated $4.81M.
  • Panoramic Capital first reported a position in Eli Lilly in Q4 2024 and held it in 6 quarters.
  • Panoramic Capital's Eli Lilly position peaked at $5.93M in Q4 2024.
  • 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Panoramic Capital's 13F filing for Q2 2026, filed 14 Aug 2026.